Home > Category > Inhibitory Antibodies > Antibodies > Adalimumab (anti-TNF-alpha)

Adalimumab (anti-TNF-alpha)

ChemLeader 95+%

Catalog No：CLA1006 CAS No.：331731-18-1 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$600.00	Visible after login	- +
5 mg	3-5days	$1600.00	Visible after login	- +
10 mg	3-5days	$2800.00	Visible after login	- +
50 mg	3-5days	$13000.00	Visible after login	- +
100 mg	3-5days	$20000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Certificate Of Authenticity(CPA)

Download COA

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Adalimumab (anti-TNF-alpha)
CAS	331731-18-1
Storage condition	Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles

Product details

Adalimumab (anti-TNF-alpha) is the first fully human, recombinant IgG1 monoclonal antibody that specifically targets human TNF-alpha, MW: 144.19 KD.

Related literature

Sorry, there is no relevant literature

Related

Sorry, no related items

History

7-Epi-10-Deacetyl Paclitaxel

78432-77-6 98+%

Adalimumab (anti-TNF-alpha)

331731-18-1 95+%

Colchicine | (-)-Colchicine | NSC 757

Docetaxel Anhydrous

114977-28-5 99+%

Valspodar (Synonyms: PSC-833;PSC833;PSC 833;6-[(2S,4R,6E)-4-methyl-2-(methylamino)-3-oxo-6-octenoic acid]-7-L-valine-cyclosporin A)

121584-18-7 98+%

Apigenin-7-glucoside

Preladenant (Synonyms: SCH-420814;SCH 420814;Privadenant;MK-3814)

377727-87-2 98+%

LY2835219 free base | Abemaciclib | LY2835219

1231929-97-7 98+%

Golimumab (Synonyms: CNTO-148; Anti-TNFSF2 / TNFa)

476181-74-5 95+%

20736-09-8 98+%